New Frontier Bio has filed a notice of an exempt offering of securities to raise $2,000,000.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, New Frontier Bio is raising up to $2,000,000.00 in new funding. Sources indicate that as part of senior management Chairman, Stephen Smith played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About New Frontier Bio
New Frontier Bio is a Boston-based technology company applying breakthrough longevity science to optimize the potential of natural compounds that improve human health by developing a portfolio of cutting-edge consumer health products including a skin health brand, and many other health optimizing brands. The company was founded in 2020 by seasoned entrepreneurs in life science industry with multiple successful exits. It is backed by renowned investors and families from the U.S., Australia and Asia. The scientific co-founders are world-class faculty from Harvard and MIT. We hold a highest standard of science and authenticity, and relentlessly pursue innovation in the field of human health.
To learn more about New Frontier Bio, visit http://www.newfrontierbio.com/
Company Linkedin Page: https://www.linkedin.com/company/new-frontier-wellness/
Contact:
Stephen Smith, Chairman
617-834-5809
https://www.linkedin.com/in/stephen-kennedy-smith-0aba124/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.